APO Research
Talk to an analyst

APO RESEARCH · REPORT

Isotopes for Nuclear Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Isotopes for Nuclear Medicine Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchIsotopes for Nuclear Medicine Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Isotopes for Nuclear Medicine Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Isotopes for Nuclear Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isotopes for Nuclear Medicine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Isotopes for Nuclear Medicine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Isotopes for Nuclear Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Isotopes for Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Isotopes for Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Isotopes for Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Isotopes for Nuclear Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Isotopes for Nuclear Medicine market include Urenco, SHINE Medical, NTP Radioisotopes, Northwest Medical Isotopes, Medical Isotopes, ITM, CMR and Cambridge Isotope Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Isotopes for Nuclear Medicine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Isotopes for Nuclear Medicine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Isotopes for Nuclear Medicine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Isotopes for Nuclear Medicine market.

Isotopes for Nuclear Medicine Segment by Company

Urenco

SHINE Medical

NTP Radioisotopes

Northwest Medical Isotopes

Medical Isotopes

ITM

CMR

Cambridge Isotope Laboratories

Isotopes for Nuclear Medicine Segment by Type

Stable Isotope

Radioisotope

Isotopes for Nuclear Medicine Segment by Application

Hospital

Laboratory

Others

Isotopes for Nuclear Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Isotopes for Nuclear Medicine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Isotopes for Nuclear Medicine key companies, revenue, market share, and recent developments.

3. To split the Isotopes for Nuclear Medicine breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Isotopes for Nuclear Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Isotopes for Nuclear Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Isotopes for Nuclear Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isotopes for Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isotopes for Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isotopes for Nuclear Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Isotopes for Nuclear Medicine industry.

Chapter 3: Detailed analysis of Isotopes for Nuclear Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Isotopes for Nuclear Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Isotopes for Nuclear Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Isotopes for Nuclear Medicine Industry Trends Table 2. Isotopes for Nuclear Medicine Industry Drivers Table 3. Isotopes for Nuclear Medicine Industry Opportunities and Challenges Table 4. Isotopes for Nuclear Medicine Industry Restraints Table 5. Global Isotopes for Nuclear Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Isotopes for Nuclear Medicine Revenue Share by Company (2021-2026) Table 7. Global Isotopes for Nuclear Medicine Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Isotopes for Nuclear Medicine Key Company Manufacturing Base & Headquarters Table 9. Global Isotopes for Nuclear Medicine Company, Product Type & Application Table 10. Global Isotopes for Nuclear Medicine Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Isotopes for Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Stable Isotope Table 15. Significant Companies of Radioisotope Table 16. Global Isotopes for Nuclear Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Isotopes for Nuclear Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Isotopes for Nuclear Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Isotopes for Nuclear Medicine Sales Value Share by Type (2021-2026) Table 20. Global Isotopes for Nuclear Medicine Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Laboratory Table 23. Significant Companies of Others Table 24. Global Isotopes for Nuclear Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Isotopes for Nuclear Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Isotopes for Nuclear Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Isotopes for Nuclear Medicine Sales Value Share by Application (2021-2026) Table 28. Global Isotopes for Nuclear Medicine Sales Value Share by Application (2027-2032) Table 29. Global Isotopes for Nuclear Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Isotopes for Nuclear Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Isotopes for Nuclear Medicine Sales Value Share by Region (2021-2026) Table 32. Global Isotopes for Nuclear Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Isotopes for Nuclear Medicine Sales Value Share by Region (2027-2032) Table 34. Global Isotopes for Nuclear Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Isotopes for Nuclear Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Isotopes for Nuclear Medicine Sales Value Market Share by Country (2021-2026) Table 37. Global Isotopes for Nuclear Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Isotopes for Nuclear Medicine Sales Value Market Share by Country (2027-2032) Table 39. Urenco Company Information Table 40. Urenco Business Overview Table 41. Urenco Isotopes for Nuclear Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Urenco Isotopes for Nuclear Medicine Product Portfolio Table 43. Urenco Recent Development Table 44. SHINE Medical Company Information Table 45. SHINE Medical Business Overview Table 46. SHINE Medical Isotopes for Nuclear Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. SHINE Medical Isotopes for Nuclear Medicine Product Portfolio Table 48. SHINE Medical Recent Development Table 49. NTP Radioisotopes Company Information Table 50. NTP Radioisotopes Business Overview Table 51. NTP Radioisotopes Isotopes for Nuclear Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. NTP Radioisotopes Isotopes for Nuclear Medicine Product Portfolio Table 53. NTP Radioisotopes Recent Development Table 54. Northwest Medical Isotopes Company Information Table 55. Northwest Medical Isotopes Business Overview Table 56. Northwest Medical Isotopes Isotopes for Nuclear Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Northwest Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio Table 58. Northwest Medical Isotopes Recent Development Table 59. Medical Isotopes Company Information Table 60. Medical Isotopes Business Overview Table 61. Medical Isotopes Isotopes for Nuclear Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio Table 63. Medical Isotopes Recent Development Table 64. ITM Company Information Table 65. ITM Business Overview Table 66. ITM Isotopes for Nuclear Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. ITM Isotopes for Nuclear Medicine Product Portfolio Table 68. ITM Recent Development Table 69. CMR Company Information Table 70. CMR Business Overview Table 71. CMR Isotopes for Nuclear Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. CMR Isotopes for Nuclear Medicine Product Portfolio Table 73. CMR Recent Development Table 74. Cambridge Isotope Laboratories Company Information Table 75. Cambridge Isotope Laboratories Business Overview Table 76. Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Product Portfolio Table 78. Cambridge Isotope Laboratories Recent Development Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Isotopes for Nuclear Medicine Product Image Figure 2. Global Isotopes for Nuclear Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isotopes for Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Isotopes for Nuclear Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Stable Isotope Image Figure 8. Radioisotope Image Figure 9. Global Isotopes for Nuclear Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Isotopes for Nuclear Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Isotopes for Nuclear Medicine Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Laboratory Image Figure 14. Others Image Figure 15. Global Isotopes for Nuclear Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Isotopes for Nuclear Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Isotopes for Nuclear Medicine Sales Value Share by Application (2021-2032) Figure 18. Global Isotopes for Nuclear Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Isotopes for Nuclear Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Isotopes for Nuclear Medicine Sales Value (2021-2032) & (US$ Million) Figure 21. North America Isotopes for Nuclear Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Isotopes for Nuclear Medicine Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Isotopes for Nuclear Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Isotopes for Nuclear Medicine Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Isotopes for Nuclear Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Isotopes for Nuclear Medicine Sales Value (2021-2032) & (US$ Million) Figure 27. South America Isotopes for Nuclear Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Isotopes for Nuclear Medicine Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Isotopes for Nuclear Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Stable Isotope
  • Radioisotope
Applications
  • Hospital
  • Laboratory
  • Others
Companies covered
  • Urenco
  • SHINE Medical
  • NTP Radioisotopes
  • Northwest Medical Isotopes
  • Medical Isotopes
  • ITM
  • CMR
  • Cambridge Isotope Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Isotopes for Nuclear Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Isotopes for Nuclear Medicine Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Isotopes for Nuclear Medicine Market Dynamics
  1. 2.1 Isotopes for Nuclear Medicine Industry Trends
  2. 2.2 Isotopes for Nuclear Medicine Industry Drivers
  3. 2.3 Isotopes for Nuclear Medicine Industry Opportunities and Challenges
  4. 2.4 Isotopes for Nuclear Medicine Industry Restraints
3 Isotopes for Nuclear Medicine Market by Company
  1. 3.1 Global Isotopes for Nuclear Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Isotopes for Nuclear Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Isotopes for Nuclear Medicine Company Ranking (2024-2026)
  4. 3.4 Global Isotopes for Nuclear Medicine Company Manufacturing Base and Headquarters
  5. 3.5 Global Isotopes for Nuclear Medicine Company Product Type and Application
  6. 3.6 Global Isotopes for Nuclear Medicine Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Isotopes for Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Isotopes for Nuclear Medicine Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Isotopes for Nuclear Medicine Market by Type
  1. 4.1 Isotopes for Nuclear Medicine Type Introduction
  2. 4.1.1 Stable Isotope
  3. 4.1.2 Radioisotope
  4. 4.2 Global Isotopes for Nuclear Medicine Sales Value by Type
  5. 4.2.1 Global Isotopes for Nuclear Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Isotopes for Nuclear Medicine Sales Value by Type (2021-2032)
  7. 4.2.3 Global Isotopes for Nuclear Medicine Sales Value Share by Type (2021-2032)
5 Isotopes for Nuclear Medicine Market by Application
  1. 5.1 Isotopes for Nuclear Medicine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Isotopes for Nuclear Medicine Sales Value by Application
  6. 5.2.1 Global Isotopes for Nuclear Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Isotopes for Nuclear Medicine Sales Value by Application (2021-2032)
  8. 5.2.3 Global Isotopes for Nuclear Medicine Sales Value Share by Application (2021-2032)
6 Isotopes for Nuclear Medicine Regional Value Analysis
  1. 6.1 Global Isotopes for Nuclear Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Isotopes for Nuclear Medicine Sales Value by Region (2021-2032)
  3. 6.2.1 Global Isotopes for Nuclear Medicine Sales Value by Region: 2021-2026
  4. 6.2.2 Global Isotopes for Nuclear Medicine Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Isotopes for Nuclear Medicine Sales Value (2021-2032)
  7. 6.3.2 North America Isotopes for Nuclear Medicine Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Isotopes for Nuclear Medicine Sales Value (2021-2032)
  10. 6.4.2 Europe Isotopes for Nuclear Medicine Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Isotopes for Nuclear Medicine Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Isotopes for Nuclear Medicine Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Isotopes for Nuclear Medicine Sales Value (2021-2032)
  16. 6.6.2 South America Isotopes for Nuclear Medicine Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Isotopes for Nuclear Medicine Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Isotopes for Nuclear Medicine Sales Value Share by Country, 2025 VS 2032
7 Isotopes for Nuclear Medicine Country-level Value Analysis
  1. 7.1 Global Isotopes for Nuclear Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Isotopes for Nuclear Medicine Sales Value by Country (2021-2032)
  3. 7.2.1 Global Isotopes for Nuclear Medicine Sales Value by Country (2021-2026)
  4. 7.2.2 Global Isotopes for Nuclear Medicine Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Isotopes for Nuclear Medicine Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Isotopes for Nuclear Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Isotopes for Nuclear Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Urenco
  2. 8.1.1 Urenco Company Information
  3. 8.1.2 Urenco Business Overview
  4. 8.1.3 Urenco Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Urenco Isotopes for Nuclear Medicine Product Portfolio
  6. 8.1.5 Urenco Recent Developments
  7. 8.2 SHINE Medical
  8. 8.2.1 SHINE Medical Company Information
  9. 8.2.2 SHINE Medical Business Overview
  10. 8.2.3 SHINE Medical Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SHINE Medical Isotopes for Nuclear Medicine Product Portfolio
  12. 8.2.5 SHINE Medical Recent Developments
  13. 8.3 NTP Radioisotopes
  14. 8.3.1 NTP Radioisotopes Company Information
  15. 8.3.2 NTP Radioisotopes Business Overview
  16. 8.3.3 NTP Radioisotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NTP Radioisotopes Isotopes for Nuclear Medicine Product Portfolio
  18. 8.3.5 NTP Radioisotopes Recent Developments
  19. 8.4 Northwest Medical Isotopes
  20. 8.4.1 Northwest Medical Isotopes Company Information
  21. 8.4.2 Northwest Medical Isotopes Business Overview
  22. 8.4.3 Northwest Medical Isotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Northwest Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio
  24. 8.4.5 Northwest Medical Isotopes Recent Developments
  25. 8.5 Medical Isotopes
  26. 8.5.1 Medical Isotopes Company Information
  27. 8.5.2 Medical Isotopes Business Overview
  28. 8.5.3 Medical Isotopes Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio
  30. 8.5.5 Medical Isotopes Recent Developments
  31. 8.6 ITM
  32. 8.6.1 ITM Company Information
  33. 8.6.2 ITM Business Overview
  34. 8.6.3 ITM Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ITM Isotopes for Nuclear Medicine Product Portfolio
  36. 8.6.5 ITM Recent Developments
  37. 8.7 CMR
  38. 8.7.1 CMR Company Information
  39. 8.7.2 CMR Business Overview
  40. 8.7.3 CMR Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CMR Isotopes for Nuclear Medicine Product Portfolio
  42. 8.7.5 CMR Recent Developments
  43. 8.8 Cambridge Isotope Laboratories
  44. 8.8.1 Cambridge Isotope Laboratories Company Information
  45. 8.8.2 Cambridge Isotope Laboratories Business Overview
  46. 8.8.3 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Product Portfolio
  48. 8.8.5 Cambridge Isotope Laboratories Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst